ATC code P01

Last updated
ATC codes
P Antiparasitic products, insecticides and repellents
Human only
P01 Antiprotozoals
P02 Anthelmintics
P03 Ectoparasiticides, including scabicides, insecticides and repellents
ATCvet only
QP51 Antiprotozoals
QP52 Anthelmintics
QP53 Ectoparasiticides, including insecticides and repellents
QP54 Endectocides

ATCcodeP01Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.Subgroup P01 is part of the anatomical group P Antiparasitic products, insecticides and repellents. [1]

The Anatomical Therapeutic Chemical (ATC) Classification System is a drug classification system that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976.

World Health Organization Specialised agency of the United Nations

The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organisation, was an agency of the League of Nations.

ATC code PAntiparasitic products, insecticides and repellents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.

Contents

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

P01A Agents against amoebiasis and other protozoal diseases

P01AA Hydroxyquinoline derivatives

P01AA01 Broxyquinoline
P01AA02 Clioquinol
P01AA04 Chlorquinaldol
P01AA05 Tilbroquinol
P01AA52 Clioquinol, combinations

P01AB Nitroimidazole derivatives

P01AB01 Metronidazole
P01AB02 Tinidazole
P01AB03 Ornidazole
P01AB04 Azanidazole
P01AB05 Propenidazole
P01AB06 Nimorazole
P01AB07 Secnidazole
P01AB51 Metronidazole, combinations

P01AC Dichloroacetamide derivatives

P01AC01 Diloxanide
P01AC02 Clefamide
P01AC03 Etofamide
P01AC04 Teclozan

P01AR Arsenic compounds

P01AR01 Arsthinol
P01AR02 Difetarsone
P01AR03 Glycobiarsol
P01AR53 Glycobiarsol, combinations

P01AX Other agents against amoebiasis and other protozoal diseases

P01AX01 Chiniofon
P01AX02 Emetine
P01AX04 Phanquinone
P01AX05 Mepacrine
P01AX06 Atovaquone
P01AX07 Trimetrexate
P01AX08 Tenonitrozole
P01AX09 Dehydroemetine
P01AX10 Fumagillin
P01AX11 Nitazoxanide
P01AX52 Emetine, combinations

P01B Antimalarials

P01BA Aminoquinolines

P01BA01 Chloroquine
P01BA02 Hydroxychloroquine
P01BA03 Primaquine
P01BA06 Amodiaquine

P01BB Biguanides

P01BB01 Proguanil
P01BB02 Cycloguanil embonate
P01BB51 Proguanil, combinations

P01BC Methanolquinolines

P01BC01 Quinine
P01BC02 Mefloquine

P01BD Diaminopyrimidines

P01BD01 Pyrimethamine
P01BD51 Pyrimethamine, combinations

P01BE Artemisinin and derivatives, plain

P01BE01 Artemisinin
P01BE02 Artemether
P01BE03 Artesunate
P01BE04 Artemotil
P01BE05 Artenimol

P01BF Artemisinin and derivatives, combinations

P01BF01 Artemether and lumefantrine
P01BF02 Artesunate and mefloquine
P01BF03 Artesunate and amodiaquine
P01BF04 Artesunate, sulphamethopyrazine and pyrimethamine
P01BF05 Artenimol and piperaquine
P01BF06 Artesunate and pyronaridine

P01BX Other antimalarials

P01BX01 Halofantrine
P01BX02 Arterolane and piperaquine

P01C Agents against leishmaniasis and trypanosomiasis

P01CA Nitroimidazole derivatives

P01CA02 Benznidazole
P01CA03 Fexinidazole

P01CB Antimony compounds

P01CB01 Meglumine antimonate
P01CB02 Sodium stibogluconate

P01CC Nitrofuran derivatives

P01CC01 Nifurtimox
P01CC02 Nitrofural

P01CD Arsenic compounds

P01CD01 Melarsoprol
P01CD02 Acetarsol

P01CX Other agents against leishmaniasis and trypanosomiasis

P01CX01 Pentamidine isethionate
P01CX02 Suramin sodium
P01CX03 Eflornithine

Related Research Articles

ATC code A02Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A02 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A03Drugs for functional gastrointestinal disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A03 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A07Antidiarrheals, intestinal anti-inflammatory/anti-infective agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A07 is part of the anatomical group A Alimentary tract and metabolism.

ATC code C01Cardiac therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C01 is part of the anatomical group C Cardiovascular system.

ATC code C03Diuretics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C03 is part of the anatomical group C Cardiovascular system.

ATC code C05Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.

ATC code C10Lipid modifying agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C10 is part of the anatomical group C Cardiovascular system.

ATC code D06Antibiotics and chemotherapeutics for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup D06 is part of the anatomical group D Dermatologicals.

ATC code G01Gynecological antiinfectives and antiseptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup G01 is part of the anatomical group G Genito-urinary system and sex hormones.

ATC code G02Other gynecologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup G02 is part of the anatomical group G Genito-urinary system and sex hormones.

ATC code M01Anti-inflammatory and antirheumatic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M01 is part of the anatomical group M Musculo-skeletal system.

ATC code M03Muscle relaxants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M03 is part of the anatomical group M Musculo-skeletal system.

ATC code N02Analgesics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup N02 is part of the anatomical group N Nervous system.

ATC code N05Psycholeptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup N05 is part of the anatomical group N Nervous system.

ATC code N07Other nervous system drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup N07 is part of the anatomical group N Nervous system.

ATC code P03Ectoparasiticides, including scabicides, insecticides and repellents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup P03 is part of the anatomical group P Antiparasitic products, insecticides and repellents.

ATC code R01Nasal preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup R01 is part of the anatomical group R Respiratory system.

ATC code R03Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup R03 is part of the anatomical group R Respiratory system.

ATCvet code QP51Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products for veterinary use. Subgroup QP51 is part of the anatomical group QP Antiparasitic products, insecticides and repellents.

Artesunate/mefloquine is a medication used to treat malaria. It is a fixed dose combination of artesunate and mefloquine. Specifically it is recommended to treat uncomplicated falciparum malaria. It is taken by mouth.

References

  1. "ATC/DDD Index 2018: code P01". WHO Collaborating Centre for Drug Statistics Methodology.